Robert Landry

Robert Landry

Director of Finance/CFO at CHECKMATE PHARMACEUTICALS, INC.

Net worth: 781 724 $ as of 2026-05-30

62 year
Health Technology
Consumer Services
Health Services

Profile

Robert E. Landry is Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. He previously was Treasurer & Senior Vice President at Pfizer Inc. Director-Pharmaceutical Marketing & Sales at Wyeth Australia Pty Ltd. Chief Financial Officer of Wyeth New Zealand and Treasurer & Principal Corporate Officer at Wyeth Corp. (which are all subsidiaries of Pfizer Inc.). Mr. Landry received an undergraduate degree from the University of Notre Dame.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-26 10,184 ( 0.01% ) 781 724 $ 2026-05-30
2026-01-11 0 ( -.--% ) - $ 2026-05-30

Robert Landry active positions

CompaniesPositionStart
CHECKMATE PHARMACEUTICALS, INC. Director of Finance/CFO 2022-05-30
DECIBEL THERAPEUTICS, INC. Director of Finance/CFO 2023-09-21
CYTOKINETICS, INCORPORATED Director/Board Member 2025-02-09
ZYMEWORKS INC. Director/Board Member 2025-08-10
Director/Board Member -

Former positions of Robert Landry

CompaniesPositionEnd
REGENERON PHARMACEUTICALS, INC. Director of Finance/CFO 2024-02-04
PFIZER INC. Corporate Officer/Principal 2012-09-30
Treasurer 2009-09-30
Wyeth Australia Pty Ltd.
Director of Finance/CFO 2005-12-31
░░░░░ ░░░ ░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Robert Landry's experience

Training of Robert Landry

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Wyeth Australia Pty Ltd.

Wyeth New Zealand

Health Technology

Health Technology

Health Services

Health Technology